Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

VUMON

TENIPOSIDE

Standard Dose
10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview VUMON is listed in Drugs@FDA under application 020119 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TENIPOSIDE Form and strength INJECTABLE;INJECTION - 10MG/ML Sponsor HQ SPECLT PHARMA Submission history Latest submission status date: 2015-03-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview VUMON is listed in Drugs@FDA under application 020119 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TENIPOSIDE Form and strength INJECTABLE;INJECTION - 10MG/ML Sponsor HQ SPECLT PHARMA Submission history Latest submission status date: 2015-03-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.